日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa

基于模型指导的噬菌体疗法开发：连接体外和体内抗多重耐药铜绿假单胞菌的疗效

期刊:mSystems
影响因子:4.6
doi:10.1128/msystems.01384-25
Cha, Jun Seok; Kim, Kyungnam; You, Hwa Jeong; Kim, Dasom; Park, Hyun Hee; Heo, SuJin; Kim, Choon Ok; Jin, Byung Hak; Yong, Dongeun; Chae, Dongwoo
发表日期：2025
文献求助 收藏

Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34(+) Cell Harvesting.

粒细胞集落刺激因子群体药代动力学-药效学模型，用于优化 CD34(+) 细胞采集的剂量和时间

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70121
Jiang Xu, Cha Jun Seok, Jin Byung Hak, Kim Choon Ok, Chae Dongwoo
细胞生物学
发表日期：2025
文献求助 收藏

Bioequivalence of a Donepezil/Memantine 10/20 mg Fixed-Dose Combination Versus Single-Component Tablets in Healthy Korean Males

多奈哌齐/美金刚10/20毫克固定剂量复方制剂与单组分片剂在健康韩国男性中的生物等效性

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.1556
Choi, Minkyu; Jin, Byung Hak; Keum, Do Hoon; Mo, Kyoung Hoon; Park, Min Soo; Lee, Juhwan; Park, Sungjin; Kim, Choon Ok
发表日期：2025
文献求助 收藏

Application of population pharmacokinetic modeling of SVG-101 to evaluate proper dose selection

应用群体药代动力学模型评估SVG-101的合理剂量选择

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2025.33.e14
Mo, Kyoung Hoon; Chae, Dongwoo; Jung, Yun Seob; Jin, Byung Hak; Keum, Do Hoon; Choi, Min Kyu; Cha, Jun Seok; Park, Min Soo; Kim, Choon Ok
发表日期：2025
文献求助 收藏

Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria

贝波他汀药代动力学模型在确定儿童过敏性鼻炎或荨麻疹患者最佳给药方案中的应用

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics16030334
Yoon, Sukyong; Jin, Byung Hak; Kim, Choon Ok; Park, Kyungsoo; Park, Min Soo; Chae, Dongwoo
麻疹
鼻炎
发表日期：2024
文献求助 收藏

Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study

基于CYP2C19表型的氯吡格雷群体药代动力学-药效学模型在剂量方案优化中的应用：概念验证研究

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13053
Jung, Yun Seob; Jin, Byung Hak; Park, Min Soo; Kim, Choon Ok; Chae, Dongwoo
发表日期：2024
文献求助 收藏

The Association between Serum Lipid Levels and Tinnitus Prevalence and Severity in Korean Elderly: A Nationwide Population-Based Cross-Sectional Study

韩国老年人血脂水平与耳鸣患病率和严重程度的相关性：一项基于全国人口的横断面研究

期刊:Yonsei Medical Journal
影响因子:2.8
doi:10.3349/ymj.2022.0626
Lee, Hye Jun; Lee, Duk Chul; Kim, Choon Ok
发表日期：2024
文献求助 收藏

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study

在健康受试者中，H4R抑制剂伊祖福兰的药代动力学、药效学和安全性：一项I期单次和多次递增剂量研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70032
Jin, Byung Hak; Hong, Taegon; Yoo, Byung Won; Kim, Choon Ok; Kim, Dasohm; Kim, Youn Nam; Park, Min Soo
发表日期：2024
文献求助 收藏

Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram

草药对艾司西酞普兰药代动力学影响的评估

期刊:Therapeutics and Clinical Risk Management
影响因子:2.2
doi:10.2147/TCRM.S448090
Jung, Yun Seob; Jin, Byung Hak; Choi, Ju Eun; Park, Min Soo; Kim, Young-Woo; Kang, Hyung Won; Cho, Sunyoung; Kim, Choon Ok
发表日期：2024
文献求助 收藏

Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro

黄龙海德汤通过 Nrf2 和 AMPK 信号通路对体内和体外神经系统疾病的抗氧化功效

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms25042313
Su-Jin Bae, Won-Yung Lee, Seon Been Bak, Seung Jin Lee, Su-Jin Hwang, Geun-Woo Kim, Byung-Soo Koo, Sun-Dong Park, Hye-Hyun Yoo, Choon-Ok Kim, Hyung Won Kang, Tae-Woo Oh, Young Woo Kim
信号转导
神经
AMPK
Neuroscience
发表日期：2024
文献求助 收藏